Neumora Therapeutics Announces $112 Million Series B Financing
Proceeds to support the advancement of Neumora’s mission of building a leading global precision neuroscience company to revolutionize the...
top of page
A L T I T U D E
Life Science Ventures
Companies in the News
bottom of page